Groundbreaking Ahead? Geron's Stem Cell Program Officially Goes to Biotime/Asteria
Geron's once-heralded stem cell therapy program -- financed at one point with $25 million from the California stem cell agency – has officially landed in the hands of an Alameda, Ca., enterprise involving two former CEOs of Geron.
Completion of the transaction was announced Tuesday by BioTime, which acquired the Geron assets. The move “could jump start g…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.